Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented a... (to treat diabetes and obesity. Amylin is...)

HOME >> MEDICINE >> TECHNOLOGY

Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009

Date:6/7/2009

to treat diabetes and obesity. Amylin is headquartered in San Diego, California.

Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help healthcare professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. Alkermes' robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, Alkermes has research facilities in Massachusetts and a commercial manufacturing facility in Ohio.

This press release contains forward-looking statements about Amylin, Lilly and Alkermes and the investigational drug, exenatide once weekly. Actual results could differ materially from those discussed or implied in this press release due to a number of risks and uncertainties, including the risk that BYETTA, exenatide once weekly, and/or the revenues generated from BYETTA and/or exenatide once weekly may be affected by competition; unexpected new data; safety and technical issues; pre-clinical trial results; clinical trials, including the clinical trial mentioned in
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
2. Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study
3. Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback
4. After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008
5. Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight
6. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
7. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
8. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
9. (RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa
10. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
11. Nebulized Perforomist(TM) Inhalation Solution Provided Prolonged Bronchodilation and Increased Patient Satisfaction Compared to Albuterol/Ipratropium MDI

Post Your Comments:

(Date:11/25/2009)...PHILADELPHIA,Nov.25/PRNewswire-FirstCall/--ERT(Nas...,theCompany,sPresidentandCEO,andKeithSchneck,theCo...presentatthe21stAnnualPiperJaffrayHealthCareConfer...rk. ,, Interestedpartiesmayaccessthepresentatio...ww.ert.com .Thewebcastmayalsobeaccessedat http://w...

(Date:11/25/2009)...EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearchGro...elara report,thefirstinamulti-phasesyndicatedmark...Biotech,sStelara,fromproductlaunchthroughthefirsts...quantitativeinformationfrom75uniqueDermatologistsa...assesstrialanduseofStelara,obstaclestouse,typicalp...

(Date:11/25/2009)...WESTPALMBEACH,Fla.,Nov.25/PRNewswire-FirstCall/--F...ciallythe27millionlivingwithuntreated hearingloss ...ndyBeyer. ,, Dr.Beyer,seniorvicepresidentofHear...d hearingaids companies,saidstudieshavelinkedheari...chcaneasilybeintensifiedatholidaygatheringswithfam...

[0] ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 [0] Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High [0] For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult

...y 31, 2007 (PRIME,NEWSWIRE) -- Infinity Pharmaceut...daq:MEDI) today announced that interim clinical,da...gastrointestinal stromal tumors (GIST) and other s...e 2007 Annual Meeting of the,American Society of C... at McCormick Place in Chicago, Ill. IPI-504, the ...

...IRE) -- Discovery,Laboratories, Inc. (Nasdaq:DSCO)...esults from its SELECT and STAR Phase 3,clinical t...medical,journal for pediatric healthcare practitio...trials concluded that Surfaxin,demonstrated a stat...to existing animal-derived surfactants, Survanta(r...

Other Medicine Technology:Infinity and MedImmune Announce Updated Data On Ipi-504 to be,Presented At ASCO 2 Infinity and MedImmune Announce Updated Data On Ipi-504 to be,Presented At ASCO 3 Infinity and MedImmune Announce Updated Data On Ipi-504 to be,Presented At ASCO 4 Infinity and MedImmune Announce Updated Data On Ipi-504 to be,Presented At ASCO 5 Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics 2 Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics 3 Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics 4 Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics 5

Infinity and MedImmune Announce Updated Data On Ipi-504 to be,Presented At ASCO Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators,Published in Pediatrics

(Date:11/25/2009)... Nationwide Imaging Services, known as one of th...nostic imaging equipment, now offering a total sol...g options, service and installation with acquisiti...nologies of California) , ... Imaging Services is proud to announce its acquisi...

(Date:11/25/2009)... BioSpace.com, the premier resource for life sci...dition of the BioForest™ Hotbed Campaign thi...O (Vocus) November 25, 2009 -- BioSpace.com, the p...mation, unveiled the third edition of the BioFores...is regional campaign is a promotional effort highl...

(Date:11/25/2009)...ertoShareRecordsSafely,ImproveCare ,, WASHING...VeteransAffairs(VA)andKaiserPermanentetodayannounc...stoourNation,sheroes.VAandKaiserPermanentearelaunc...EHR)informationusingtheNationwideHealthInformation...nServices. ,, "Theabilitytosharecriticalhealthi...

(Date:11/25/2009)...v.25/PRNewswire/--dazzlesmile,llc www.dazzlesmile....cience.com havefileda67-pagefederallawsuitagainstE...seWillms,FarendServicesLimited,andAtLastFulfillmen...trictCourtfortheDistrictofUtah,allegesmassivenatio...andedteethwhiteningproducts,violationsoftheRackete...

(Date:11/25/2009)...ov.25/PRNewswire/--DanielTouizer,CEOof Ci n e ...healthinsurancebenefitprograms,isconcernedthatthel...lyoneinfiveAmericansarewithoutafull-timejobandunli...ratesaredeterminedbytheU-6number,whichhasspikedto1... T ouizer ."Thesestatisticsarealarmingasitmeans...

Breaking Medicine News(10 mins):Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2 Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3 Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2 Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2 Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2 Health News:Cinergy Health Commentary on Health Care for the Unemployed 2

[0] Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) [1] BioSpace Showcases Leading Life-Science Companies in the Northwest [0] VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program [0] dazzlesmile Sues Epic Advertising and Jesse Willms [0] Cinergy Health Commentary on Health Care for the Unemployed

...untain of Life is excited to announce that the Dav...ip product, VaNu. , , "Golfers drinking VaNu r... focus, better health, and an improved sense of we...ately became interested in the beverage after lear...

...los Endoscopy, Inc. (Pink Sheets: SNDY) is pleased...roduct line, the MammoView(TM), was featured in t...agazine in the December 2008 issue. The article fo...w(TM) product line employs advanced microendoscope...

...loped for assay kits from Beacon Analytical System...oplate readers with SoftMax(R), Pro analytical ...FirstCall/ - MDS Analytical Technologies, a leader...nalytical Systems, which focuses on the developmen...

... 19 The Providence Service Corporation (Nasdaq: ... has been awarded a $1.5 million annual contract t...ess center in Orange County, California. The cont...ed delivery model is very much aligned with Orange...

...f., Feb. 19 Based on its recent analysis of the N...p; Sullivan recognizes Horphag Research Ltd. with ...lence in Research of the Year Award. The award ack...ingredient, Pycnogenol(R), across industries such ...

...., Feb. 19 Smith & Nephew,s Advanced Wound Ma...d that the United States Patent and Trademark Offi...ree of KCI,s negative pressure wound therapy (NPWT...re-examined claims are not patentable, including t...

Other Medicine News:Health News:World-Renowned Golf Instructor David Leadbetter Promotes VaNu 2 Health News:Solos Endoscopy, Inc.'s MammoView(TM) Featured in December Issue of Surgical Products Magazine 2 Health News:MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food 2 Health News:MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food 3 Health News:MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food 4 Health News:Providence Service Corporation California Subsidiary Awarded $1.5 Million Contract Under State's Mental Health Services Act 2 Health News:Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health Ingredients 2 Health News:Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health Ingredients 3 Health News:Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health Ingredients 4 Health News:United States Patent Office Rejects KCI's Patents 2 Health News:United States Patent Office Rejects KCI's Patents 3

World-Renowned Golf Instructor David Leadbetter Promotes VaNu Solos Endoscopy, Inc.'s MammoView(TM) Featured in December Issue of Surgical Products Magazine MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food Providence Service Corporation California Subsidiary Awarded $1.5 Million Contract Under State's Mental Health Services Act Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health Ingredients United States Patent Office Rejects KCI's Patents

Neuropack MEB-7102 Evoked Potential Measuring System

Neuropack MEB-2200 Evoked Potential/EMG Measuring System

Myoquick 1200/1400/1800

Sierra Wave

Medicine Products:

Neuropack MEB-7102 Evoked Potential Measuring System Neuropack MEB-2200 Evoked Potential/EMG Measuring System Myoquick 1200/1400/1800 Sierra Wave

Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented a...(to treat diabetes and obesity. Amylin is...),Health